Recanalization devices should be restricted to clinical trials: pro (kind of).
Schellinger
Peter D
PD
Department of Neurology, University of Erlangen, Schwabachanlage 6, Erlangen, Germany D-91054. peter.schellinger@uk-erlangen.de
Hacke
Werner
W
D002404:Catheterization / Q000295:instrumentation / Q000379:methods; D002986:Clinical Trials as Topic / Q000295:instrumentation* / Q000379:methods*; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000473:pathology / Q000628:therapy; D015912:Thrombolytic Therapy / Q000295:instrumentation* / Q000379:methods*; D014654:Vascular Patency
D005343:Fibrinolytic Agents